GGrantIndex
← Leaderboards

Aimee L Edinger

University Of Pennsylvania

$7,408,519
Attributed
$8,537,064
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,537,064 · 7

By mechanism

R01$5,171,265 · 3
T32$1,919,228 · 1
R21$757,261 · 2
K08$689,310 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsTumorNutrientPublishingCancer CellTraffickingCessation Of LifeSignal TransductionPathway InteractionsResponseProteinsPreventLysosomesToxic EffectMetabolismStarvationAnalogDoseFda ApprovedMalignant NeoplasmsCell DeathGrowthMolecularSphingolipids

Grant awards (29)

Accelerating the translation of oligonucleotide therapeutics by enhancing delivery$419,398
R21 · FY2025 · TR · contact PI
A Training Program for Interdisciplinary Cancer Research$333,547
T32 · FY2025 · CA
A novel strategy to overcome drug resistance in cancer$295,488
R01 · FY2025 · CA · contact PI
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance$456,227
R01 · FY2024 · CA · contact PI
A novel strategy to overcome drug resistance in cancer$444,318
R01 · FY2024 · CA · contact PI
A Training Program for Interdisciplinary Cancer Research$420,050
T32 · FY2024 · CA
A novel strategy to overcome drug resistance in cancer$480,820
R01 · FY2023 · CA · contact PI
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance$447,367
R01 · FY2023 · CA · contact PI
A Training Program for Interdisciplinary Cancer Research$417,865
T32 · FY2023 · CA
A Training Program for Interdisciplinary Cancer Research$354,454
T32 · FY2022 · CA
A novel strategy to overcome drug resistance in cancer$238,727
R01 · FY2022 · CA · contact PI
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance$109,595
R01 · FY2022 · CA · contact PI
A novel strategy to overcome drug resistance in cancer$497,379
R01 · FY2021 · CA · contact PI
A Training Program for Interdisciplinary Cancer Research$393,312
T32 · FY2021 · CA
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance$349,523
R01 · FY2021 · CA · contact PI
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance$348,993
R01 · FY2020 · CA · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$279,146
R01 · FY2014 · GM · contact PI
Identification of the anti-neoplastic target of bioactive FTY720 analogs$143,357
R21 · FY2014 · CA · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$270,402
R01 · FY2013 · GM · contact PI
Identification of the anti-neoplastic target of bioactive FTY720 analogs$194,506
R21 · FY2013 · CA · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$325,276
R01 · FY2012 · GM · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$333,887
R01 · FY2011 · GM · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$8,588
R01 · FY2011 · GM · contact PI
Effects of sphingolipids on nutrient transporter expression and bioenergetics$285,529
R01 · FY2010 · GM · contact PI
Regulation of nutrient access by growth factors and mTOR$137,862
K08 · FY2007 · CA · contact PI
Regulation of nutrient access by growth factors and mTOR$137,862
K08 · FY2006 · CA · contact PI
Regulation of nutrient access by growth factors and mTOR$137,862
K08 · FY2005 · CA
Regulation of nutrient access by growth factors and mTOR$137,862
K08 · FY2004 · CA
Regulation of nutrient access by growth factors and mTOR$137,862
K08 · FY2003 · CA